featured
Pioglitazone/Exenatide Improves Beta Cell Function and Glycemic Control Compared With Basal/Bolus Insulin in Poorly Controlled T2DM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combination Therapy With Pioglitazone/Exenatide Improves Beta Cell Function and Produces Superior Glycemic Control Compared to Basal/Bolus Insulin in Poorly Controlled T2DM: 3-Year Follow-Up of the Qatar Study
Diabetes Obes Metab 2020 Jul 30;[EPub Ahead of Print], M Abdul-Ghani, O Migahid, A Megahed, RA DeFronzo, E Al-Ozairi, A JayyousiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.